AzTrials
AzTrials

MalocclusionNCT07039071

Evaluation of Clinical and Patient-Reported Outcomes of Laceback

A study testing Laceback in people with Malocclusion, run by International Islamic University Malaysia at 1 site in Malaysia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate oral hygiene status, archwire complications, laceback complications, and pain while using lacebacks in patients undergoing orthodontic fixed appliance treatment. The main questions it aims to answer are: 1. Read more about this study

Who is it for?
Ages 15 years and older
Conditions the study is for
Malocclusion
What is being tested?
Laceback
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteMalaysia
Study dates
9 Mar 2026to Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patient factors
  • Age 15 and above
  • Medically fit and well
  • Good oral hygiene - no dental caries, Basic Periodontal Examination (BPE) score 0
  • Orthodontic factors
  • Full upper and lower arch fixed orthodontic treatment (bonded till first permanent molars)
Show all 9Show fewer
  • Pre-adjusted edgewise appliance with 0.022" slot, MBT prescription, Master Series® brackets (American Orthodontics, USA)
  • Extraction of bilateral upper and lower permanent first/second premolars
  • No previous orthodontic treatment

Who cannot join

  • Craniofacial deformities
  • Mental or physical disability leading to impaired manual dexterity, difficulty in comprehending and following oral hygiene instructions
  • Underlying chronic medical illness, oral diseases

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dr. Tan Loon Han contact

+60123790908

tanloonhan@gmail.com

Assistant Professor Dr. Siti Hajjar Binti Nasir contact

+6095705505

drhajjar@iium.edu.my

Malaysia1 site, 1 recruiting
  • Department of Orthodontics, Kulliyah of Dentistry, International Islamic University Malaysia

    Kuantan, Pahang, 25200

    Assistant Professor Dr. Siti Hajjar Binti Nasir, +6095705505, drhajjar@iium.edu.my

    Assistant Professor Dr. Cheong Joo Ming, +6095705484, alvinjooming@iium.edu.my

    Recruiting

Other trials in Malaysia

About this study

Official title: Evaluation of Clinical and Patient-Reported Outcomes of Laceback: A Split-Mouth Randomised Controlled Trial

The goal of this clinical trial is to evaluate oral hygiene status, archwire complications, laceback complications, and pain while using lacebacks in patients undergoing orthodontic fixed appliance treatment.

The main questions it aims to answer are:

Read more
  1. What is the effect of laceback on patient's oral hygiene during alignment phase of orthodontic fixed appliance treatment?
  2. What is the effect of laceback on the frequency of archwire complications during alignment phase of orthodontic fixed appliance treatment?
  3. What is the frequency of laceback complications during alignment phase of orthodontic fixed appliance treatment?
  4. What is the effect of laceback on pain during alignment phase of orthodontic fixed appliance treatment?

For each subject, researchers will randomly assign half of the oral cavity to receive laceback during orthodontic fixed appliance treatment, whereas the other half will not receive laceback. Researchers will then compare the effect of laceback on patient's oral hygiene, archwire complications, laceback complications, and pain.

Participants are required to carry out the usual oral hygiene practices after braces and laceback are being put up. During the observation period, they are required to notify the researcher if they suspect any breakages or loose components, so that they come to the clinic for emergency appointments. They are also required to fill up a pain diary.

Read the detailed description

Aim:

To evaluate the clinical and patient-reported outcomes of laceback usage during alignment phase of orthodontic fixed appliance treatment.

Specific Objectives:

  1. To assess the effect of laceback on patient's oral hygiene during alignment phase of orthodontic fixed appliance treatment.
  2. To investigate the effect of laceback on the frequency of archwire complications during alignment phase of orthodontic fixed appliance treatment.
  3. To determine the frequency of laceback complications during alignment phase of orthodontic fixed appliance treatment.
  4. To study the effect of laceback on pain during alignment phase of orthodontic fixed appliance treatment.

Research questions:

  1. What is the effect of laceback on patient's oral hygiene during alignment phase of orthodontic fixed appliance treatment?
  2. What is the effect of laceback on the frequency of archwire complications during alignment phase of orthodontic fixed appliance treatment?
  3. What is the frequency of laceback complications during alignment phase of orthodontic fixed appliance treatment?
  4. What is the effect of laceback on pain during alignment phase of orthodontic fixed appliance treatment?

Study design:

Split-mouth randomised controlled trial. For each subject, researchers will randomly assign half of the oral cavity to receive laceback during orthodontic fixed appliance treatment, whereas the other half will not receive laceback.

Population (P) - Orthodontic patients from International Islamic University Malaysia (IIUM) aged 15 and above.

Intervention (I) - Laceback (LB) Control (C) - No laceback (no LB) Outcome (O) - Primary outcome: Plaque score (using Orthodontic Plaque Index)

Secondary outcomes:

Frequency of archwire complications Frequency of laceback complications Pain (using Visual Analogue Scale)

Study procedures:

One week after braces are put up, participants will be called back so that the researchers can put up laceback on one side of their oral cavity, and record baseline records of their oral hygiene using the Orthodontic Plaque Index (OPI). Participants are required to carry out the usual oral hygiene practices after braces and laceback are being put up. During the next 8 week observation period, they are required to notify the researcher if they suspect any breakages or loose components, so that they come to the clinic for emergency appointments. They are also required to fill up a pain diary for 4 weeks at specific time points, where pain will be recorded using a Visual Analogue Scale. After 4 weeks, participants will be recalled so that the researchers collect the pain diary, and record the plaque score, and any archwire/laceback complications. This is repeated for another 4 weeks whereby pain diary is filled up for 4 weeks at specific time points, and on the 8th week, subjects will be reclled so that the researchers collect the pain diary, and record the plaque score, and any archwire/laceback complications.

Sampling method:

Convenience sampling of orthodontic patients from the Specialist and Postgraduate Orthodontic Clinic of the Kulliyyah of Dentistry, IIUM.

Sample size calculation:

Sample size is calculated based on each specific objective. Sample size calculated for specific objective 1 was the highest and was therefore chosen.

Specific objective 1 is to assess the effect of laceback on patient's oral hygiene during alignment phase of orthodontic fixed appliance treatment. A previous split-mouth study was conducted on orthodontic patients to record their plaque score using OPI. The standard deviation (SD) of OPI was calculated to be 1.88. A difference of 1 point in OPI was deemed clinically meaningful to be detected. The sample size is calculated using G*Power (Version 3.1.9.6). A total of 34 subjects are required for 68 sites (34 LB and 34 no LB), which would give a power of 85% with significance level of 0.05 to detect 1 unit difference in OPI score. Final sample size after considering 10% drop out rate is 38 patients (38 per group).

Randomisation:

Two-stage randomisation strategy will be employed - simple randomisation, followed by minimisation (covariate adaptive randomisation). For the first 10 subjects, simple randomisation is applied. For the subsequent 28 subjects, allocation will be determined using minimisation method. This is to balance the prespecified covariates between laceback and no laceback groups - type of premolar extracted and side of allocating laceback.

Allocation concealment is achieved by sequentially numbered, opaque, sealed envelopes containing allocation card written "left" or "right" side for laceback. As new subjects are recruited, an independent dental nurse opens the next envelope in the sequence to reveal the allocation. The prinicipal investigator is responsible for recruiting and implementing the intervention.

Blinding:

Due to the nature of the study, the participants and operator are not blinded. Some of the data collection can be blinded, i.e. recording of plaque score. During recall visits, laceback and archwires will be removed, then plaque disclosing agent will be applied. Then, plaque score will be recorded by a clinician not involved in treating the patient. All data collected will be coded and anonymised to ensure that the data analyst is blinded. The code will be held by the co-investigator and will only be revealed to the principal investigator after data analysis is completed.

Proposed statistical analysis:

Data will be analysed using IBM SPSS Statistics for Macintosh (Version 27). Normality of data will be assessed using shape of the distribution curve and Shapiro-Wilk test. Reliability assessments will be measured using Intraclass Correlation Coefficient with threshold set at 0.8 to indicate good inter- and intra-rater reliability. An intention-to-treat analysis will be employed. Missing pain scores will be imputed by last observation carried forward method.

Baseline demographic characteristics will be analysed using descriptive statistics.

For specific objective 1, to compare differences in mean plaque score between LB and no LB group over time (T0, T1, and T2), a two-way repeated measures ANOVA test will be applied if data is normally distributed. When a significant main effect or interaction is detected, post-hoc pairwise comparisons will be performed using simple effects analysis with Bonferroni correction. If normality assumption is violated, Friedman test will be applied instead.

For specific objective 2, the mean frequency of archwire complications will be recorded by summing up the number of complications that happen throughout the study period from T0 to T2. To compare differences in mean frequency of archwire complications between LB and no LB group, a paired t-test will be used if data is normally distributed. If normality assumption is violated, Wilcoxon signed-rank test will be applied instead.

For specific objective 3, mean frequency of laceback complications per subject will be reported. The number and percentage of subjects with at least two laceback complications will also be reported.

For specific objective 4, to compare differences in mean pain score between LB and no LB group over time (T0, T0 - T1, and T1 - T2), a two-way repeated measures ANOVA test will be applied if data is normally distributed. When a significant main effect or interaction is detected, post-hoc pairwise comparisons will be performed using simple effects analysis with Bonferroni correction. If normality assumption is violated, Friedman test will be applied instead.

Conditions
Malocclusion
Being tested
Laceback
Keywords
laceback, pain, plaque score, archwire, complication, breakage
Medical subject headings
Malocclusion, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LacebackDevice

    Lacebacks are a kind of orthodontic auxilliaries used during the initial phase of orthodontic fixed appliance treatment, especially in premolar extraction cases. They are 0.010" stainless steel ligatures tied in figure-of-8 fashion beneath the main archwires, from the canine bracket till the first molar hook of one quadrant. For this study, on the side that is randomly allocated to receive laceback, laceback will be put on both upper and lower arches (from canine bracket to 1st molar hook).

Study groups in NCT07039071
Study groupRoleWhat they receive
LacebackExperimentalFor this study, on the side of the oral cavity that is randomly allocated to receive laceback, lacebacks will be put on both upper and lower arches.
Receives: Device: Laceback
No lacebackNo interventionOn the other side of the oral cavity, no laceback will be placed.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plaque score

    Plaque score will be recorded using Orthodontic Plaque Index (OPI). After removing laceback and archwires, the OPI is scored by blinded clinician after applying plaque disclosing agent on canine, premolar, first molar. Visually examine presence/absence of plaque at tooth surface adjacent to bracket base (mesial, distal, occlusal, gingival), and the condition of the gingival margin.

    The status is scored according to the criteria below:

    Score 0 - Brackets are plaque-free Score 1 - Plaque on 1 tooth surface at bracket base Score 2 - Plaque on 2 tooth surfaces at bracket base Score 3 - Plaque on 3 tooth surfaces at bracket base Score 4 - Plaque on 4 tooth surfaces at bracket base and/or gingival inflammation

    Mean OPI for LB and no LB side is calculated by adding up plaque score of all the teeth recorded on each side, and dividing it by the number of teeth scored.

    Inter and intrarater reliability testing will be done.

    Measured: T0 (baseline) - before placing laceback. T1 - 4 weeks after T0 T2 - 4 weeks after T1

Secondary outcomes (3)
  1. Frequency of archwire complications

    For the purpose of this study, archwire complications will include the following:

    • Archwire fractured at any part distal to the canine bracket - counted as one incident.
    • Archwire dislodged from one or more canine bracket, premolar bracket, or first molar tube - counted as one incident.
    • Archwire permanently deformed at any part distal to the canine bracket - counted as one incident.
    • Any combination of the above three situations - counted as one incident.
    • Whole archwire lost - counted as one incident each on both LB and no LB sides.

    Upper and lower archwires will be visually examined when the patient is first seen during the appointment. The number of complications of upper and lower archwires are summed up for each side. Total number of archwire complications throughout study period will be recorded for LB side and no LB side.

    Measured: T1 - 4 weeks after T0 T2 - 4 weeks after T1 And whenever patient comes for emergency appointment between T0 and T1, and T1 to T2

  2. Frequency of laceback complications

    For the purpose of this study, laceback complications will include the following:

    • Laceback ligature fractured at any part - counted as one incident.
    • Laceback ligature dislodged from one or more brackets of canine, premolar, and first molar hook - counted as one incident.
    • A combination of the above two situations - counted as one incident.
    • Whole laceback lost - counted as one incident.

    Upper and lower lacebacks will be visually examined when the patient is first seen during the appointment. The number of complications of upper and lower lacebacks are summed up. Total number of laceback complications throughout study period will be recorded. During emergency appointments, dislodged lacebacks will be retied using the same protocol described previously, whereas broken or missing laceback will be replaced using new but same type of preformed 0.010" stainless steel wire ligature (Ormco Corporation, United States of America) in the same manner.

    Measured: T1 - 4 weeks after T0 T2 - 4 weeks after T1 And whenever patient comes for emergency appointment between T0 and T1, and T1 an T2

  3. Pain during orthodontic treatment

    Pain on LB and no LB side will be recorded using Visual Analogue Scale (VAS) in a pain diary. Subjects will be reminded via phone to complete the diary at home, and it will be collected back during T1. They will be asked to rate the maximum pain on each side during 4 hr, 24 hr, 3 days, 1 week, 2 weeks, 3 weeks after laceback placement. Subjects will place a mark along a 100 mm horizontal line at the most relevant position, whereby the left extreme indicates "no pain and discomfort" and the right extreme indicates "worst imaginable pain and discomfort". VAS will be measured to the nearest 1 mm using a metal ruler from the low end of the scale to the patient's mark (score 0-100). Each pain score reading will be accompanied by an open-ended question asking what is the cause of pain. Analgesics should not be taken prophylactically - score should reflect maximum pain before analgesics. From the diary, the highest pain score throughout T0-T1 is recorded for LB and no LB side.

    Measured: During appointment, T0 (baseline) - before laceback placement. Inside pain diary, between T0 to T1 and T1 to T2 at specific time points - 4 hours, 24 hours, 3 days, 1 week, 2 weeks, 3 weeks, 4 weeks after laceback placement.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2025
  2. Study start9 Mar 2026
  3. Primary completionJun 2027 (estimated)
  4. Study completionSep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Split-mouth RCT - a within person trial. One side of the oral cavity will receive laceback, whereas the other side will act as control (no laceback).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
38 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07039071
Sponsor's protocol ID
IIUM_Laceback
Status last verified
May 2026
First submitted
18 Jun 2025
Last updated
13 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Patient confidentiality. And will require permission from Director General of Health Malaysia

Publications

  • Zinelis S, Eliades T, Pandis N, Eliades G, Bourauel C. Why do nickel-titanium archwires fracture intraorally? Fractographic analysis and failure mechanism of in-vivo fractured wires. Am J Orthod Dentofacial Orthop. 2007 Jul;132(1):84-9. doi: 10.1016/j.ajodo.2005.11.039.

    PubMed 17628255
  • V S B, Kaul A, Tiwari A, Aliya S, Yadav A, Bera T, Kaur Makkad P. Assessment of Various Archwire Materials and Their Impact on Orthodontic Treatment Outcomes. Cureus. 2024 Sep 18;16(9):e69667. doi: 10.7759/cureus.69667. eCollection 2024 Sep.

    PubMed 39429425
  • Usmani T, O'Brien KD, Worthington HV, Derwent S, Fox D, Harrison S, Sandler PJ, Mandall NA. A randomized clinical trial to compare the effectiveness of canine lacebacks with reference to canine tip. J Orthod. 2002 Dec;29(4):281-6; discussion 277. doi: 10.1093/ortho/29.4.281.

    PubMed 12444268
  • Sueri MY, Turk T. Effectiveness of laceback ligatures on maxillary canine retraction. Angle Orthod. 2006 Nov;76(6):1010-4. doi: 10.2319/100605-351.

    PubMed 17090165
  • Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020 Sep 1;161(9):1976-1982. doi: 10.1097/j.pain.0000000000001939.

    PubMed 32694387
  • Kozak U, Lasota A, Chalas R. Changes in Distribution of Dental Biofilm after Insertion of Fixed Orthodontic Appliances. J Clin Med. 2021 Nov 29;10(23):5638. doi: 10.3390/jcm10235638.

    PubMed 34884339
  • Popat H, Thomas K, Farnell DJ. Management of orthodontic emergencies in primary care - self-reported confidence of general dental practitioners. Br Dent J. 2016 Jul 8;221(1):21-4. doi: 10.1038/sj.bdj.2016.495.

    PubMed 27388086
  • Peterson BW, Tjakkes GH, Renkema AM, Manton DJ, Ren Y. The oral microbiota and periodontal health in orthodontic patients. Periodontol 2000. 2024 Jul 19. doi: 10.1111/prd.12594. Online ahead of print.

    PubMed 39031969
  • Pandis N, Walsh T, Polychronopoulou A, Katsaros C, Eliades T. Split-mouth designs in orthodontics: an overview with applications to orthodontic clinical trials. Eur J Orthod. 2013 Dec;35(6):783-9. doi: 10.1093/ejo/cjs108. Epub 2013 Feb 1.

    PubMed 23376899
  • Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG. CONSORT 2010 statement: extension checklist for reporting within person randomised trials. BMJ. 2017 Jun 30;357:j2835. doi: 10.1136/bmj.j2835.

    PubMed 28667088
  • Mokhtari S, Sanati I, Babaki FA, Alamdari S, Tavana N. Investigating the effect of handedness on the dental caries pattern, gingival index, and plaque index in 6-10 years old children. Niger J Clin Pract. 2020 Apr;23(4):545-549. doi: 10.4103/njcp.njcp_600_19.

    PubMed 32246663
  • McLaughlin RP, Bennett JC. The transition from standard edgewise to preadjusted appliance systems. J Clin Orthod. 1989 Mar;23(3):142-53. No abstract available.

    PubMed 2606968
  • Marsh PD. Dental plaque as a microbial biofilm. Caries Res. 2004 May-Jun;38(3):204-11. doi: 10.1159/000077756.

    PubMed 15153690
  • Marincak Vrankova Z, Rousi M, Cvanova M, Gachova D, Ruzicka F, Hola V, Lochman J, Izakovicova Holla L, Brysova A, Borilova Linhartova P. Effect of fixed orthodontic appliances on gingival status and oral microbiota: a pilot study. BMC Oral Health. 2022 Oct 27;22(1):455. doi: 10.1186/s12903-022-02511-9.

    PubMed 36303145
  • Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016 Jun;15(2):155-63. doi: 10.1016/j.jcm.2016.02.012. Epub 2016 Mar 31.

    PubMed 27330520

Questions about this trial

What is this clinical trial studying?

A study testing Laceback in people with Malocclusion, run by International Islamic University Malaysia at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dr. Tan Loon Han (+60123790908, tanloonhan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plaque score (time frame: T0 (baseline) - before placing laceback. T1 - 4 weeks after T0 T2 - 4 weeks after T1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07039071, which also lists 26 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in